Prevention of intravascular infections ways and means

Journal of Intravenous Nursing

Volumn 19, Issue 4, 1996, Pages 175-181

  Crow, Sue ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; HEPARIN; SILVER;

ASEPSIS; CATHETER INFECTION; DISINFECTION; HAND WASHING; HEPARINIZATION; HUMAN; INTRAVENOUS CATHETER; POLICY; REVIEW; RISK FACTOR; WOUND DRESSING;

BACTEREMIA; CROSS INFECTION; HUMANS; INFECTION CONTROL; INFUSIONS, INTRAVENOUS; RISK FACTORS;

EID: 0030057994     PISSN: 08965846     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Crow S. Editorial: the call. Seminars in Perioperative Nursing. 1994;3:59-60.
2. Maki DG. Pathogenesis, prevention, and management of infections due to intravascular devices used for infusion therapy. In: Bisno AL, Waldvogel FA, eds. Infections Associated with Indwelling Medical Devices. Washington DC: American Society for Microbiology, 1989;161-177.
3. Maki DG. Nosocomial bacteremia: an epidemiologic overview. Am I Med 1981;70:719-732.
4. Norwood S. Ruby, Civetta J, Cortes V, Catheter-related infections and associated septicemia. Chest 199;99:969-975.
5. Elliott TS, Faroquit MH, Armstrong RF, Hanson GC. Guidelines for good practice in central venous catheterization. Journal of Hospital Infections 1994;28:163-176.
6. Maki DG. Nosocomial bacteremia. Am J Med 1981;70: 183-196.
7. Clemence MA, Walker D, Farr BM. Central venous catheter practices: results of a survey. Am J Infect Control 1995;23: 5-12.
8. Maki DG, Botticelli JT, Leroy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. JAMA 1987;258:1777-1781.
9. Widmer AF. IV-related infections. In: Prevention and Control of Nosocomial Infections, Second Edition. Wenzel RP, ed. Baltimore: Williams & Wilkins, 1987:556-579.
10. Maki DG. Infections Caused by Intravascular Devices Used for Infusion Therapy: Pathogenesis, Prevention, and Management in Infections Associated With Indwelling Medical Devices. Bisno AI, Waldvogel FA, ed. Washington: American Society For Microbiology, 1994:155-212
11. Crow S. Asepsis: The Right Touch; Something Old Is Now New. Bossier City, LA: Everett Publishing, 1989.
12. Thur MP, Miller WA, Latiolais CJ. Medication errors in a nurse-controlled parenteral admixture program. American Journal of Hospital Pharmacy 1972;April 29:298-304.
13. Cohen MR. It's Up To You To Do Something About Medication Errors, Here Are The Problems And The Solutions. ASHP Midyear Clinical Meeting. New Orleans: Institute For Safe Medication Practices, Inc., 1991.
14. Bates DW, Cullen DJ, Laird NL, et al. Incidence of adverse drug events and potential adverse drug events. JAMA 1995;274: 29-34.
15. Brown BJ, Mackowiak PA, Smith JW. Care of veins during intravenous therapy: incidence of phlebitis as related to knowledge and performance. Am J Infect Control 1980;8:107-112.
16. Puntis JWL, Holden CE, Smallman S, Finkel Y, George RH, Booth IW. Staff training: a key factor in reducing intravascular catheter sepsis. Arch Dis Children 1991;66:335-337.
17. Vanherweghem JL, Dhaene M, Goldman M, Stolear JC, Sabot JP, Waterlot Y, Surruys E, Thayse C. Infections associated with subclavian dialysis catheters: the key role of nurse training. Nephron 1986;42:116-119.
18. Centers for Disease Control and Prevention. Draft Guidelines for Prevention of Intravascular Device-Related Infections: Part 1. Intravascular Device-Related Infections: An Overview. Part 2. Recommendations for Prevention of Intravascular Device-Related Infections; Notice of Comment Period. Federal Register, Notices 60(187), Wednesday, September 17, 1995.
19. Campbell AB. Benchmarking: a performance intervention tool. Journal On Quality Improvement 1994;20:225-228.
20. Mosel D, Gift B. Collaborative benchmarking in health care. Journal On Quality Improvement 1994;20:239-249.
21. Steere AC, Mallison GF. Handwashing practices for the prevention of nosocomial infections. Ann Intern Med 1975;83: 683-690.
22. Garner JS, Favero MS. CDC guideline for handwashing and hospital environmental control, 1986. Infection Control 1986;7:231-243.
23. Issacs D, Dickson H, O'Callaghan C, et al. Handwashing and cohorting in prevention of hospital acquired infection with respiratory syncytial virus. Arch Dis Children 1991;66:227-231.
24. Larson E, Leyden JJ, Mcginley KJ, et al. Physiological and microbiologic changes in skin related to frequent handwashing. Infection Control 1986;7:59-63.
25. Larson E, Leyden JJ, Mcginley RJ, et al. Physiological and microbiologic changes in skin related to frequent handwashing. Infection Control 1986;7:59-63.
26. Maki DG, Zilz MA, Alvarado CJ. Evaluation of the antibacterial efficacy of four agents for handwashing. Current Chemotherapy In Infectious Disease 1980;11:1089-1090.
27. Maki D, Ringer M, Alvarado C. Prospective randomized trial of povidone-iodine alcohol and chlorhexidine for prevention of infection associated with central venous line arterial catheters. Lancet 1991;338:33.
28. Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, Marts K, Mansfield PF, Bodey GP. Prevention of central venous catheter-related infections by using maximal barrier precautions during insertion, infection control and hospital epidemiology. 1994;15:231-238.
29. Linares J, Sitges-Serra A, Garau J, Et Al. Pathogenesis of catheters sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. Journal of Clinical Microbiology 1985;21:357-360.
30. Sitges-Serra A, Linares J, Garau J. Catheter sepsis: the clue is the hub. Surgery 1985;97:355-357.
31. Moro JL, Vigano EF, Lepri AC. Risk factors for central venous catheter-related infections in surgical and intensive care units. Infection Control and Hospital Epidemiology 1994;15: 253-264.
32. Sitges-Serra A, Puig P, Linares J, Perez JL, Farrer N, Jaurrieta E, Garau J. Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. JPEN 1984;8:668-672.
33. Stotter AT, Ward H, Waterfield AH, Sim AJW. Junctional care: the key to prevention of catheter sepsis in intravenous feeding. JPEN 1987;11:159-162.
34. Maki DG, Botticelli JT, Leroy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48 vs 72-hour intervals. JAMA 1987;258:1777-1781.
35. Band JD, Maki DG. Safety of changing intravenous delivery systems at longer than 24-hour intervals. Ann Intern Med 1979;91:173-178.
36. Snydman DR, Donnelly-Reidy M, Perry LK, Martin WJ. Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infection Control 1987;8:113-116.
37. Couchonnal GJ, Hodges GR, Barnes WG, Elemets CA, Clark GM. Complications with heparin-lock needles. JAMA 1979;242:2098-2100.
38. American Society of Hospital Pharmacists. ASHP therapeutic position statement on the institutional use of 0.9% sodium chloride injection to maintain patency of peripheral indwelling intermittent infusion devices. Journal of Intravenous Nursing 1994;17:287-289.
39. Gehbart F. Pharmacy warning: IV bag flush may be endangering patients. Hospital Pharmacists Report, June 1994.
40. Cohen MR. Intravenous bags as multiple-dose containers pose danger; another vincristine error; article misprints does of chemotherapy, antibiotic withdrawal. Hospital Pharmacy 1994; 29:724-726.
41. Conly J, Grieves K, Peters B. A prospective, randomized study comparing transparent and dry gauze dressing for central venous catheters. J Infect Dis 1989;159:310-319.
42. Katich M, Band J. Local infection of the intravenous-cannulae wound associated with transparent dressings. Journal of Infectious Diseases 1985;151:971-972.
43. Powell C, Regan C, Fabri P, Ruberg R. Evaluation of opsite catheter dressings for parenteral nutrition: a prospective randomized study. JPEN 1982;6:43-46.
44. Maki D, Stoliz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Critical Care Medicine 1994;22:1729-1737.
45. Wille JC, Van Oud Alblas B, Thewesen EAPM. Evaluation of complications with prolonged use of transparent film-type dressings with central venous, catheters. A comparison of opsite IV 3000 dressings in improving catheter site care. Maki DG, ed. New York Royal Society Of Medicine Services, 1993: 41-53.
46. Maki DG, Stolz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Critical Care Medicine 1994;22:1729-1737.
47. Petrakis S, Rodvien R, Garmhausen LW, Koruda MJ. The Effects of Biopatch Antimicrobial Dressings for Insertion Site Management of Indwelling Central Venous Catheters. Poster Presentation: National Association of Vascular Access Networks, September 24-26, 1992, New Orleans, LA; and Intravenous Nurses Society, April 30-May 5, 1994, Denver, CO.
48. Shapiro JM, Bond EL, Garman JK. Use of chlorhexidine dressing to reduce microbial colonization of epidural catheters. Anesthesiology 1990;73:625-631.
49. Trooskin SZ, Donetz AP, Harvey RA, Greco RS. Prevention of catheter sepsis by antibiotic bonding. Surgery 1985;97: 547-551.
50. Kamal GD, Pfaller MA, Rempe LE, Jebson JR. Reduced intravascular catheter infection by antibiotic bonding: a prospective, randomized, controlled trial. JAMA 1991;265:2364-2368.
51. Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med 1988;85:307-314.
52. Flowers RH, Schwenzer KJ, Kopel RF, Fisch M, Tucker SI, Farr BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection, a randomized, controlled trial. JAMA 1989;261:878-883.